One Personality Type Is More Prone to Be an Anti-Vaxxer
FRIDAY, Aug. 4, 2023 (HealthDay News) — When studying which personality types were more likely to resist getting vaccines, researchers got a surprise. It was the extroverts who were more vaccine resistant. Compared to other personality styles, extrov…
Learn MoreTroubled Childhood Could Mean a Troubled Old Age, Study Finds
FRIDAY, Aug. 4, 2023 (HealthDay News) — The trauma and unhappy family dynamics of childhood may follow kids into old age, affecting both their mind and body, according to new research. “We looked at self-reported disability, as well as objectively me…
Learn MoreEarly-Stage Cancer Diagnoses Decreased During First Year of COVID-19
THURSDAY, Aug. 3, 2023 (HealthDay News) — The number of cancer diagnoses decreased following COVID-19 emergence in March 2020, with the largest decrease seen for stage I disease, according to a study published in the August issue of The Lancet Oncolo…
Learn MorePeople With Mental Disorders Less Likely to Complete CRC Screening
THURSDAY, Aug. 3, 2023 (HealthDay News) — People with mental disorders are less likely to participate in colorectal cancer screening versus those without these disorders, according to a study published in the July issue of The Lancet Psychiatry.Mette…
Learn MoreFDA Approves Second OTC Naloxone Spray for Suspected Opioid Overdose
THURSDAY, Aug. 3, 2023 (HealthDay News) — The U.S. Food and Drug Administration has approved RiVive, an over-the-counter (OTC) naloxone hydrochloride nasal spray for emergency treatment of known or suspected opioid overdose.”We know naloxone is a pow…
Learn MoreLead Exposure in Utero or in Childhood Tied to Higher Risk for Criminal Behavior
THURSDAY, Aug. 3, 2023 (HealthDay News) — There is a higher risk for criminal behavior in adulthood when an individual is exposed to lead in utero or in the early years of childhood, according to a review published online Aug. 1 in PLOS Global Public…
Learn MoreLawsuit Against Makers of Ozempic, Mounjaro Claim Meds Caused ‘Stomach Paralysis’
THURSDAY, Aug. 3, 2023 (HealthDay News) — A Louisiana woman is suing the makers of two type 2 diabetes drugs used off-label for obesity, saying they failed to adequately warn about the risk for severe stomach problems.The lawsuit seeks “very signific…
Learn MoreUna pastilla contra la depresión postparto se ve bien en un ensayo, y podría ser aprobada por la FDA
MIÉRCOLES, 2 de agosto de 2023 (HealthDay News) — Esta semana, todos los ojos están puestos en la Administración de Alimentos y Medicamentos (FDA) de EE. UU., mientras la agencia sopesa la aprobación de una nueva pastilla que podría tratar y aliviar …
Learn More¿Podría la exposición al plomo a una edad temprana aumentar las probabilidades de criminalidad más adelante?
MIÉRCOLES, 2 de agosto de 2023 (HealthDay News) — Ser expuesto al plomo en el útero o en la niñez temprana podría aumentar las probabilidades de que una persona se implique en conductas criminales en la adultez, afirma una nueva revisión. Para llegar…
Learn MoreLas mamografías asistidas por IA podrían ser un importante avance, según un estudio
MIÉRCOLES, 2 de agosto de 2023 (HealthDay News) — Los programas de inteligencia artificial (IA) pueden ser utilizados de forma segura para ayudar a los radiólogos a revisar las imágenes de las mamografías y detectar cánceres de mama, muestran los res…
Learn More